These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7536607)

  • 1. A reappraisal of serial isotope bone scans in prostate cancer.
    O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF
    Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
    Shih WJ; Wierzbinski B; Collins J; Magoun S; Chen IW; Ryo UY
    J Nucl Med; 1990 Sep; 31(9):1486-9. PubMed ID: 1697617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
    Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
    J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
    Bruwer G; Heyns CF; Allen FJ
    Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S; Liehn JC; Desoize B; Larbre H; Deltour G; Valeyre J
    Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
    Barichello M; Gion M; Bonazza A; Delli Ponti US; Bolgan A; Contemori GP; Barioli P; Capitanio G; Pecori B; Omacini S
    Eur Urol; 1995; 27(4):295-300. PubMed ID: 7544735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
    Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
    Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
    Hetherington JW; Siddall JK; Cooper EH
    Eur Urol; 1988; 14(1):1-5. PubMed ID: 2449352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
    Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
    Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.
    Wolff JM; Bares R; Jung PK; Buell U; Jakse G
    Urol Int; 1996; 56(3):169-73. PubMed ID: 8860738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
    Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?
    Yap BK; Choo R; Deboer G; Klotz L; Danjoux C; Morton G
    BJU Int; 2003 May; 91(7):613-7. PubMed ID: 12699470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How significant are serial bone scans in monitoring advanced prostatic cancer?
    Tekgül S; Ozen H; Ozyavuz R; Bakkaloğlu M; Remzi D
    Int Urol Nephrol; 1995; 27(1):87-91. PubMed ID: 7615375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
    Oesterling JE; Martin SK; Bergstralh EJ; Lowe FC
    JAMA; 1993 Jan; 269(1):57-60. PubMed ID: 7677962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of serum prostate specific antigen levels and bone scintigraphy in carcinoma prostate.
    Oommen R; Geethanjali FS; Gopalakrishnan G; Chacko N; John S; Kanagasabapathy AS; Roul RK
    Br J Radiol; 1994 May; 67(797):469-71. PubMed ID: 7514940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer.
    Rudoni M; Antonini G; Favro M; Baroli A; Brambilla M; Cardani G; Ciardi L; Sacchetti GM; Inglese E
    Eur J Nucl Med; 1995 Mar; 22(3):207-11. PubMed ID: 7540551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.